NM

Naresh Midha

Active Director Director DIN 10573915
DIN 10573915 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Naresh Midha

Data last updated:

Naresh Midha is a Director at Curcumentis Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10573915
Primary Designation Director
Industry Paper
First Appointment 01 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20242024Under Process Of Striking Off

Board colleagues of Naresh Midha

NameDINCompanyDesignation
Gurander Rai Diwan10573916Curcumentis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curcumentis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Naresh Midha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Midha

Naresh Midha currently holds 1 directorship: Curcumentis Pharmaceuticals Private Limited (Director, since 01 Apr 2024).

Naresh Midha was first appointed on 01 Apr 2024 as Director at Curcumentis Pharmaceuticals Private Limited.

The current boards of Naresh Midha's companies include Gurander Rai Diwan (Curcumentis Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available